Associations of systemic sphingolipids with measures of hepatic function in liver cirrhosis are related to cholesterol.

Krautbauer, Sabrina; Wiest, Reiner; Liebisch, Gerhard; Buechler, Christa (2017). Associations of systemic sphingolipids with measures of hepatic function in liver cirrhosis are related to cholesterol. Prostaglandins & other lipid mediators, 131, pp. 25-32. Elsevier 10.1016/j.prostaglandins.2017.06.004

[img] Text
1-s2.0-S1098882317300503-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Download (1MB) | Request a copy

Lipoprotein particles are composed of various lipid classes including cholesterol and sphingolipids, and are low in serum of patients with liver cirrhosis. Hepatic decompensation is associated with a further decline of lipoproteins. Aim of the present work was to evaluate whether ceramide and sphingomyelin species are similarly changed in patients with liver cirrhosis and whether these variations are related to systemic cholesterol levels. In a cohort of 45 patients suffering from liver cirrhosis, cholesteryl ester species and subsequently total cholesterol were identified to be negatively associated with model of end stage liver disease (MELD) score. Indeed, the negative correlations of ceramide (Cer) and sphingomyelin (SM) species with MELD score, bilirubin and anti-thrombin 3 were non-significant after adjustment for cholesterol. Cer/SM ratios of species with identical acyl chains were not related to Child-Pugh or MELD score indicating that both lipids are comparably changed. Further, cholesterol levels and concentrations of all sphingolipids measured were similar in systemic, hepatic vein and portal vein blood. Cholesterol and distinct sphingolipids were similar before and 3 months after insertion of a transjugular intrahepatic portosystemic shunt while hexosylceramide 24:1 was significantly induced. It is concluded that analysis of distinct systemic sphingolipid species is not superior to measurement of cholesterol as non-invasive marker of hepatic injury in patients with liver cirrhosis.

Item Type:

 Journal Article (Original Article)

Division/Institute:

 04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Gastroenterology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Gastroenterologie / Mukosale Immunologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Gastroenterologie / Mukosale Immunologie

UniBE Contributor:

 Wiest, Reiner

Subjects:

 600 Technology > 610 Medicine & health

ISSN:

 1098-8823

Publisher:

 Elsevier

Language:

 English

Submitter:

 Thi Thao Anh Pham

Date Deposited:

 01 Feb 2018 12:23

Last Modified:

 05 Dec 2022 15:10

Publisher DOI:

 10.1016/j.prostaglandins.2017.06.004

PubMed ID:

 28647317

Uncontrolled Keywords:

 Ascites Lipoprotein MELD score Transjugular intrahepatic portosystemic shunt

BORIS DOI:

 10.7892/boris.110318

URI:

 https://boris.unibe.ch/id/eprint/110318

Actions (login required)

Edit item Edit item
Provide Feedback